Home
About us
- Team
- Board
- CAB
- Investors
Our Science
- ISM-001
News & Events
- News
- Events
Contact us

Connect with us

© Copyright 2024 Isomab

Author: pconington

IsomAb Announces Strategic Collaboration with Catalent

Posted on October 29, 2024November 4, 2024 by pconington

Posted in Uncategorized

Search

Recent Posts

IsomAb makes two key appointments; Dr Shi Yin Foo as Non-Executive Director and Dr Gary Burgess as CMO
IsomAb Announces Strategic Collaboration with Catalent
IsomAb Announces Nomination of Development Candidate for Peripheral Arterial Disease and Strategic Collaboration with Pfizer
IsomAb Announces the Expansion of its Clinical Advisory Board
IsomAb Appoints Dr Anker Lundemose as a Non-Executive Director

Recent Comments

No comments to show.

Archives

February 2025
October 2024
July 2024
April 2024
February 2024

Categories

Uncategorized

Terms of use

Privacy Policy & Cookies

© Copyright 2024 Isomab

Connect with us